High c‐Met expression in stage I–II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|309-0167|5|664-676

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.309-0167, Iss.5, 2015-11, pp. : 664-676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High c‐Met expression in stage I–II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis

By  

HISTOPATHOLOGY, Vol. 67, Iss. 5, 2015-11 ,pp. : 664-676

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of p27 Expression Is Associated with Poor Prognosis in Stage I–II Pancreatic Cancer

By  

Oncology, Vol. 65, Iss. 4, 2004-01 ,pp. : 371-377

Karger

Access to resources Recommend Favorite

High Frequency of c-Met Expression in Gastric Cancers Producing Alpha- Fetoprotein

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 145-151

Karger

Access to resources Recommend Favorite

High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma

By  

HISTOPATHOLOGY, Vol. 66, Iss. 7, 2015-06 ,pp. : 955-965

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of E-Cadherin Expression Is Associated with a Poor Prognosis in Stage III Colorectal Cancer

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 318-328

Karger

Access to resources Recommend Favorite